KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Hologic (HOLX) Divestments (2017 - 2023)

Hologic (HOLX) has disclosed Divestments for 9 consecutive years, with -$31.3 million as the latest value for Q4 2023.

Quarterly Divestments changed N/A to -$31.3 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was -$31.3 million through Sep 2024, changed N/A year-over-year, with the annual reading at -$31.3 million for FY2024, N/A changed from the prior year.
Divestments hit -$31.3 million in Q4 2023 for Hologic, down from -$3.4 million in the prior quarter.
In the past five years, Divestments ranged from a high of -$3.4 million in Q3 2020 to a low of -$31.3 million in Q4 2023.